Cite
Ito Z, Takakura K, Suka M, et al. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017;13(6):4799-4805doi: 10.3892/ol.2017.6071.
Ito, Z., Takakura, K., Suka, M., Kanai, T., Saito, R., Fujioka, S., Kajihara, M., Yanagisawa, H., Misawa, T., Akiba, T., Koido, S., & Ohkusa, T. (2017). Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncology letters, 13(6), 4799-4805. https://doi.org/10.3892/ol.2017.6071
Ito, Zensho, et al. "Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma." Oncology letters vol. 13,6 (2017): 4799-4805. doi: https://doi.org/10.3892/ol.2017.6071
Ito Z, Takakura K, Suka M, Kanai T, Saito R, Fujioka S, Kajihara M, Yanagisawa H, Misawa T, Akiba T, Koido S, Ohkusa T. Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma. Oncol Lett. 2017 Jun;13(6):4799-4805. doi: 10.3892/ol.2017.6071. Epub 2017 Apr 21. PMID: 28599481; PMCID: PMC5453115.
Copy
Download .nbib